Medical Xpress·3 min read·medium
Mass-producible immune cells kill patient-derived colorectal tumors in mice
K
Kobe University
✦AI Summary
Kobe University researchers have developed a method to mass-produce immune cells derived from T cells that can effectively target and shrink colorectal tumors in mice. This breakthrough could lead to faster and more affordable cancer immunotherapies.
edited by Sadie Harley , reviewed by Robert Egan
sciencehealth
✦
Get the full story
Sign up for Headlinne to unlock AI insights, political bias analysis, and your personalized news feed.
Create free accountAlready have an account? Sign in